Halifax Pharmaceuticals Private Limited
About Halifax Pharmaceuticals Private Limited
Data last updated:
Halifax Pharmaceuticals Private Limited is a private limited company based in Bettiah, Bihar, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 12 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2018PTC040233. Its GSTIN is 10AAECH7413D1Z9 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Minu Rai and Rinki Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O – Santosh Rai Rajendar Nagar Ward No – 4 Kali Bagh, Bettiah, Bihar, India – 845438.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.92 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹22,344 (net margin -4.5%) and EBITDA of ₹10,634 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years.
Company details
Contact details
Halifax Pharmaceuticals Private Limited's registered office is in Bettiah, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O – Santosh Rai Rajendar Nagar Ward No – 4 Kali Bagh, Bettiah, Bihar, India – 845438
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Halifax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Halifax Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Halifax Pharmaceuticals Private Limited, buy the company report.
Financials of Halifax Pharmaceuticals Private Limited
FY 2023 filings availableHalifax Pharmaceuticals Private Limited reported revenue of ₹4.92 Lakh (down 3% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 73%. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,634 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹22,344 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | -4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Halifax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Halifax Pharmaceuticals Private Limited
Halifax Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Minu Rai | Director | 12 Dec 2018 | 7 Years 11 Months | Current |
| Rinki Singh | Director | 12 Dec 2018 | 7 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Halifax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Halifax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Halifax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECH7413D1Z9 | Bihar | Active | 27 Jan 2020 |
To see the full GST registrations and return filing status of Halifax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Halifax Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Jeetendra Kumar ceased to be Director on 07 Aug 2021.
Frequently asked questions
Halifax Pharmaceuticals is an active private limited company based in Bettiah, Bihar, India. The company works in specialty, within the trading industry. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U51909BR2018PTC040233.
Halifax Pharmaceuticals has 2 current directors:
- Minu Rai - Director
- Rinki Singh - Director
The latest financial statements of Halifax Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Halifax Pharmaceuticals is 10AAECH7413D1Z9, registered in Bihar.
The CIN (Corporate Identification Number) of Halifax Pharmaceuticals is U51909BR2018PTC040233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halifax Pharmaceuticals was incorporated on 12 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
Jeetendra Kumar ceased to be Director on 07 Aug 2021. Minu Rai was appointed as Director on 12 Dec 2018. Rinki Singh was appointed as Director on 12 Dec 2018.
The registered office of Halifax Pharmaceuticals is at CO – Santosh Rai Rajendar Nagar Ward No – 4 Kali Bagh, Bettiah, Bihar, India – 845438.
Halifax Pharmaceuticals operates in the trading industry, in the specialty segment.
Halifax Pharmaceuticals can be reached at its registered office: CO – Santosh Rai Rajendar Nagar Ward No – 4 Kali Bagh, Bettiah, Bihar, India – 845438.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
